Relationship between direct cortical stimulation and induced high-frequency activity for language mapping during SEEG recording.


Journal

Journal of neurosurgery
ISSN: 1933-0693
Titre abrégé: J Neurosurg
Pays: United States
ID NLM: 0253357

Informations de publication

Date de publication:
24 Apr 2020
Historique:
received: 10 10 2019
accepted: 13 02 2020
pubmed: 25 4 2020
medline: 31 7 2021
entrez: 25 4 2020
Statut: epublish

Résumé

The authors assessed the clinical relevance of preoperative task-induced high-frequency activity (HFA) for language mapping in patients with refractory epilepsy during stereoelectroencephalography recording. Although HFA evaluation was described as a putative biomarker of cognition, its clinical relevance for mapping language networks was assessed predominantly by studies using electrocorticography (ECOG). Forty-two patients with epilepsy who underwent intracranial electrode implantation during both task-induced HFA and direct cortical stimulation (DCS) language mapping were evaluated. The spatial and functional relevance of each method in terms of specificity and sensitivity were evaluated. The results showed that the two methods were able to map classic language regions, and a large and bilateral language network was obtained with induced HFA. At a regional level, differences were observed between methods for parietal and temporal lobes: HFA recruited a larger number of cortical parietal sites, while DCS involved more cortical temporal sites. Importantly, the results showed that HFA predicts language interference induced by DCS with high specificity (92.4%; negative predictive value 95.9%) and very low sensitivity (8.9%; positive predictive value 4.8%). DCS language mapping appears to be more appropriate for an extensive temporal mapping than induced HFA mapping. Furthermore, induced HFA should be used as a complement to DCS to preselect the number of stimulated sites during DCS, by omitting those reported as HFA-. This may be a considerable advantage because it allows a reduction in the duration of the stimulation procedure. Several parameters to be used for each method are discussed and the results are interpreted in relation to previous results reported in ECOG studies.

Identifiants

pubmed: 32330883
doi: 10.3171/2020.2.JNS192751
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1251-1261

Auteurs

Pauline Cuisenier (P)

1Department of Neurology, CHU Grenoble Alpes, Grenoble.

Bénédicte Testud (B)

2Université Grenoble Alpes, CNRS, LPNC UMR 5105, Grenoble.

Lorella Minotti (L)

1Department of Neurology, CHU Grenoble Alpes, Grenoble.
3Université Grenoble Alpes, Institut des Neurosciences, GIN, Grenoble.

Samuel El Bouzaïdi Tiali (S)

2Université Grenoble Alpes, CNRS, LPNC UMR 5105, Grenoble.

Laurence Martineau (L)

1Department of Neurology, CHU Grenoble Alpes, Grenoble.

Anne-Sophie Job (AS)

1Department of Neurology, CHU Grenoble Alpes, Grenoble.
3Université Grenoble Alpes, Institut des Neurosciences, GIN, Grenoble.

Agnès Trébuchon (A)

4Aix Marseille Université, INSERM, INS, Institut de Neurosciences des Systèmes, Marseille.

Pierre Deman (P)

3Université Grenoble Alpes, Institut des Neurosciences, GIN, Grenoble.

Manik Bhattacharjee (M)

3Université Grenoble Alpes, Institut des Neurosciences, GIN, Grenoble.

Dominique Hoffmann (D)

1Department of Neurology, CHU Grenoble Alpes, Grenoble.

Jean-Philippe Lachaux (JP)

5INSERM, U1028, CNRS, UMR5292, Lyon Neuroscience Research Center, Brain Dynamics and Cognition Team, DYCOG, Lyon.
6Université Lyon 1, Lyon, France; and.

Monica Baciu (M)

2Université Grenoble Alpes, CNRS, LPNC UMR 5105, Grenoble.
7Institut Universitaire de France.

Philippe Kahane (P)

1Department of Neurology, CHU Grenoble Alpes, Grenoble.
4Aix Marseille Université, INSERM, INS, Institut de Neurosciences des Systèmes, Marseille.

Marcela Perrone-Bertolotti (M)

2Université Grenoble Alpes, CNRS, LPNC UMR 5105, Grenoble.
7Institut Universitaire de France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH